Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Frontiers in Immunology|October 17, 2018
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment EfficacyMohamed I M Ahmed, Nyanda E Ntinginya, Gibson Kibiki, et al.The Lancet. HIV|April 12, 2025
Impact of quasi-elimination of Wuchereria bancrofti on HIV incidence in southwest Tanzania: a 12-year prospective cohort studyInge Kroidl, Thomas F Marandu, Lucas Maganga, et al.PLOS Global Public Health|October 14, 2024
New admissions and asymptomatic TB cases seem to fuel TB epidemic in prisons, a cross sectional survey in TanzaniaChacha David Mangu, Petra Clowes, Jan van den Hombergh, et al.Frontiers in Oncology|December 17, 2021
HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East AfricaRuby Mcharo, Tessa Lennemann, John France, et al.Virology|March 4, 2022
The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 - Results from a prospective cohort of outpatient COVID-19 casesKerstin Puchinger, Noemi Castelletti, Raquel Rubio-Acero, et al.The Lancet. Infectious Diseases|September 23, 2024
Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB studyLaura Olbrich, Zoe Franckling-Smith, Leyla Larsson, et al.Virology Journal|September 1, 2023
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparisonInge Kroidl, Simon Winter, Raquel Rubio-Acero, et al.BMC Infectious Diseases|September 8, 2021
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)Katja Radon, Abhishek Bakuli, Peter Pütz, et al.International Journal of Environmental Research and Public Health|April 3, 2021
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort MunichMichael Pritsch, Katja Radon, Abhishek Bakuli, et al.The Journal of General Virology|October 8, 2021
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2Laura Olbrich, Noemi Castelletti, Yannik Schälte, et al.Pageof 8